Anti-mouse CD52 Treatment Ameliorates Colitis through Suppressing Th1/17 Mediated Inflammation and Promoting Tregs Differentiation in IL-10 Deficient Mice. [electronic resource]
Producer: 20190220Description: 1423-1429 p. digitalISSN:- 1347-5215
- Animals
- CD52 Antigen -- antagonists & inhibitors
- Cell Differentiation -- drug effects
- Colitis -- drug therapy
- Female
- Inflammation Mediators -- antagonists & inhibitors
- Interleukin-10 -- deficiency
- Male
- Mice
- Mice, Inbred C3H
- Mice, Knockout
- T-Lymphocytes, Regulatory -- drug effects
- Th1 Cells -- drug effects
- Th17 Cells -- drug effects
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.